Keto refers to a diet low in carbs and high in fat. As one of the more popular fad diets in recent years, you’ve likely heard of it before. However, the question remains: is keto good for you?
Some potential benefits of the keto diet include providing treatment for individuals with epilepsy and diabetes. Nonetheless, as a diet that requires people to consume the majority of their calories from fat, it is not sustainable for everyone. There are even some potential risks from following the ketogenic diet, such as the keto flu, low blood pressure, and nutrient deficiencies.
All in all, the keto diet can be beneficial for individuals with some pre-existing conditions. Regardless, it may not be the best diet for everyone. It’s recommendable to speak to your physician before beginning with the keto diet.
Find out more on Eatdat.
Helms, Natalie. “Is the Keto Diet Safe? What Are the Risks?” UChicago Medicine, UChicago Medicine, 20 June 2019, www.uchicagomedicine.org/forefront/health-and-wellness-articles/ketogenic-diet-what-are-the-risks.
Shilpa, Joshi, and Viswanathan Mohan. “Ketogenic Diets: Boon or Bane?” The Indian Journal of Medical Research, Medknow Publications & Media Pvt Ltd, Sept. 2018, www.ncbi.nlm.nih.gov/pmc/articles/PMC6251269/.
Ułamek-Kozioł, Marzena, et al. “Ketogenic Diet and Epilepsy.” Nutrients, MDPI, 18 Oct. 2019, www.ncbi.nlm.nih.gov/pmc/articles/PMC6836058/.
EC, Westman, et al. “Implementing a Low-Carbohydrate, Ketogenic Diet to Manage Type 2 Diabetes Mellitus.” Expert Review of Endocrinology & Metabolism, U.S. National Library of Medicine, 13 Sept. 2018, pubmed.ncbi.nlm.nih.gov/30289048/.
Rusek, Marta, et al. “Ketogenic Diet in Alzheimer’s Disease.” International Journal of Molecular Sciences, MDPI, 9 Aug. 2019, www.ncbi.nlm.nih.gov/pmc/articles/PMC6720297/.
Bostock, Emmanuelle C S, et al. “Consumer Reports of ‘Keto Flu’ Associated With the Ketogenic Diet.” Frontiers in Nutrition, Frontiers Media S.A., 13 Mar. 2020, www.ncbi.nlm.nih.gov/pmc/articles/PMC7082414/.
V;, Qiu H;Novikov A;Vallon. “Ketosis and Diabetic Ketoacidosis in Response to SGLT2 Inhibitors: Basic Mechanisms and Therapeutic Perspectives.” Diabetes/Metabolism Research and Reviews, U.S. National Library of Medicine, pubmed.ncbi.nlm.nih.gov/28099783/.